Dr. Jorge Fradinho | Medicine | Best Researcher Award

Dr. Jorge Fradinho | Medicine | Best Researcher Award

Dr. Jorge Fradinho | Medicine – Emergency Medicine Instructor at Beth Israel Deaconess Medical Center, United States

Dr. Jorge Miguel dos Santos Fradinho is an accomplished scholar, systems thinker, and healthcare innovator with a career that spans over two decades in research, education, and policy design. A thought leader at the intersection of engineering systems and healthcare delivery, he has held academic and strategic leadership roles at premier institutions, including the Massachusetts Institute of Technology (MIT) and Harvard Medical School. His work is recognized for its real-world impact, particularly in emergency medicine, military psychological health, and enterprise transformation. Known for integrating technical depth with management acumen, Dr. Fradinho continues to advance value-based care strategies while mentoring the next generation of global healthcare leaders.

Profile:

Orcid | Scopus

Education:

Dr. Fradinho’s academic journey is marked by consistent excellence across top global institutions. He earned a Bachelor of Science in Computer Science and Electronic Engineering from University College London, followed by a Master of Science in Information Systems Analysis and Design from the London School of Economics. He later completed dual graduate degrees—an MEng in Logistics and Supply Chain and a Ph.D. in Engineering Systems—from the Massachusetts Institute of Technology. His doctoral work, supervised by pioneers in systems thinking, examined high-performing hospital architectures and systems-of-systems approaches for health delivery.

Experience:

With a rich blend of academic, consulting, and hospital leadership experience, Dr. Fradinho has contributed significantly to both theory and practice. He has served as a Principal Research Scientist at MIT, directed strategy and analytics at Beth Israel Deaconess Medical Center, and advised on systems transformation projects for the U.S. Department of Defense, VA Health System, and major European Commission R&D initiatives. He is currently an Instructor in Emergency Medicine at Harvard Medical School, where he combines clinical insight with research to improve health system performance.

Research Interests:

Dr. Fradinho’s research focuses on the intersection of systems engineering, digital transformation, and population health. His interests include health systems design, emergency medicine quality improvement, military and veteran psychological health, enterprise architecture, and integrated care models. His work is known for applying hybrid methods—quantitative modeling, enterprise analysis, and policy mapping—to uncover systemic inefficiencies and inform sustainable innovation in healthcare delivery.

Awards:

Dr. Fradinho has received multiple accolades throughout his career. He was awarded a prestigious five-year doctoral fellowship from the Portuguese Foundation for Science and Technology, placing in the top three nationwide. At MIT, he became the first recipient of the Graduate Teaching Award in his department’s history—an honor recognizing his exceptional impact on graduate education. Additionally, his research on healthcare cost reduction and quality improvement was recognized with a dedicated $80,000 grant from the Lahey Clinic.

Selected Publications 📚:

  1. The Value of Using a Quality Assurance Follow-Up Team to Address Incidental Findings After Emergency Department or Urgent Care Discharge: A Cost Analysis 🏥📈
  2. The effect of increasing emergency department observation volumes on downstream admission rates. 💡🧾

Conclusion:

Dr. Jorge Miguel dos Santos Fradinho exemplifies the spirit of research excellence, systemic thinking, and socially impactful scholarship. His visionary approach to improving healthcare systems through engineering and policy design has resulted in measurable outcomes in cost, quality, and care coordination. As both a researcher and a mentor, he uplifts institutions and individuals alike. His body of work, supported by robust funding, global recognition, and a deep commitment to education, makes him an outstanding candidate for the Best Researcher Award.

 

 

 

Selvia Hanna | Clinical Pharmacy | Best Researcher Award

Dr. Selvia Hanna | Clinical Pharmacy | Best Researcher Award

Senior Clinical Pharmacist | Beni-Suef University Hospital | Egypt

👩‍🔬 Short Bio:

Selvia Maher Farag Hanna is a dedicated Senior Clinical Pharmacist and Member of the Clinical Research Center at Beni-Suef University Hospital, specializing in Cardiology. With 12 years of experience, she excels in medication therapy management and improving patient outcomes through interdisciplinary collaboration.

Profile:

SCOPUS

📚 Education:

Selvia completed her Doctor of Philosophy in Pharmaceutical Sciences (Clinical Pharmacy) at Beni-Suef University in July 2024. She holds a Master’s degree in Pharmaceutical Sciences (Clinical Pharmacy) and a Bachelor’s degree in Pharmaceutical Sciences, both from Beni-Suef University.

💼 Experience:

Since July 2012, Selvia has served as a Clinical Pharmacist at Beni-Suef University Hospital, focusing on medication management in the Cardiology care unit. Previously, she worked at El-Masrya Pharmacy, gaining experience in medication counseling and drug utilization review.

🔬 Research Interest:

Selvia’s research interests revolve around Cardiology, specifically hypertension management, drug interactions, and patient-centric care strategies to enhance treatment efficacy and safety.

🏆 Award:

Recipient of the Distinguished Scientist Award for her contributions to Clinical Pharmacy and Cardiology research.

📄 Publications:

  1. Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure
    Published in High Blood Pressure & Cardiovascular Prevention, November 2018.
    View Publication
    Cited 11 times.
  2. Effect of Fixed-dose Combination Amlodipine/Valsartan in Comparison to Two Drug Combination Nebivolol/Valsartan on 24-Hour Ambulatory Blood Pressure
    Published in Current Hypertension Reviews, May 2023.
    View Publication
  3. Target Blood Pressure and Combination Therapy: Focus on Angiotensin Receptor Blockers Combination with Either Calcium Channel Blockers or Beta Blockers
    Published in Current Hypertension Reviews, September 2022.
  4. Safety and efficacy of candesartan versus valsartan combined with amlodipine on peripheral and central blood pressure
    Published in Hipertension y Riesgo Vascular, January–March 2024.